AngioWaveNet vs SENSICARDIAC

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Angiowave Imaging
VS
by Diacoustic Medical Devices (Pty) Ltd.

AI Verdict

AngioWaveNet enhances fluoroscopic angiograms to improve vessel visualization in cardiac catheterization laboratories, focusing on image post-processing for interventional procedures. SENSICARDIAC, on the other hand, utilizes AI to detect and classify heart murmurs via electronic stethoscopes, primarily aiding in early diagnosis and reducing unnecessary referrals. While both are cardiology AI tools, they address distinct diagnostic challenges and integrate into different clinical workflows.

Choose AngioWaveNet if…

Choose AngioWaveNet if your cardiac catheterization laboratory requires enhanced fluoroscopic angiogram visualization during interventional procedures. This AI software is ideal for improving the clarity of blood vessels and anatomical features, integrating seamlessly into existing Cath lab workflows to support more precise interventions. It's particularly suited for environments where optimizing image quality for complex vascular structures is critical.

View AngioWaveNet →

Choose SENSICARDIAC if…

Choose SENSICARDIAC if you need an AI-powered solution for early heart murmur detection and classification, particularly in a primary care, pediatric, or telehealth setting. This tool is best for physicians utilizing electronic stethoscopes who aim to quickly differentiate between pathological and physiological murmurs, thereby aiding in diagnosis and reducing unnecessary specialist referrals. It provides a guided auscultation process and detailed reports for efficient cardiac screening.

View SENSICARDIAC →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AngioWaveNet SENSICARDIAC
Pricing Pricing options include annual software licensing or subscription-based access, tailored to cath lab volume and hospital needs. custom packages are available. Unknown
Deployment Cloud-based or on-premise/servers SensiCardiac is a software package running on a Windows PC that interfaces with compatible electronic stethoscopes. SensiCardiac Mobi runs on a mobile device (iPhone 4S or later) and interfaces with a hosted Linux server environment. The related Telesensi platform operates entirely in the browser.
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AngioWaveNet

AngioWaveNet is designed for seamless integration into existing Cath lab workflows and is compatible with any fluoroscopic angiography system, functioning as a DICOM endpoint. This vendor-agnostic approach and automatic post-processing minimize disruption and training needs. SENSICARDIAC, while offering a guided auscultation process and real-time analysis, requires integration with specific electronic stethoscopes, which may limit its universal plug-and-play usability across all clinical settings.

Clinical Value

Tie

Both tools offer significant and FDA-cleared clinical value in different areas of cardiology. AngioWaveNet enhances fluoroscopic angiograms for improved vessel visualization, aiding in diagnostic confidence and procedural precision during cardiac catheterization. SENSICARDIAC provides AI-powered heart murmur detection, classifying murmurs to assist in diagnosis and reduce unnecessary referrals, with reported high accuracy in clinical studies. Their impact on patient care is substantial but distinct.

Pricing & Value

AngioWaveNet

AngioWaveNet offers more transparent and flexible pricing options, including annual software licensing or subscription-based access tailored to cath lab volume and hospital needs, with custom packages available. SENSICARDIAC's pricing is not publicly available, requiring direct contact for a quote, which makes it harder for potential customers to assess immediate value and compare options.

Enterprise Readiness

AngioWaveNet

Both tools are FDA-cleared and HIPAA compliant, essential for enterprise adoption. However, AngioWaveNet offers both cloud-based and on-premise deployment options, providing greater flexibility for diverse hospital IT infrastructures and security policies. Its vendor-agnostic compatibility and DICOM endpoint functionality also ensure broader integration with existing imaging systems, enhancing its readiness for large-scale enterprise deployment.

Innovation

SENSICARDIAC

While AngioWaveNet's AI-powered Spatiotemporal Enhancement Processing (STEPu2122) for angiograms is a sophisticated application of image processing, SENSICARDIAC demonstrates a slightly higher degree of innovation by integrating real-time AI analysis of live physiological data with electronic stethoscopes. This approach provides immediate diagnostic aid at the point of care, including guided auscultation and detailed cardiac reports, directly impacting the diagnostic workflow in a novel way.

Support & Docs

Tie

Neither the provided structured facts nor web searches yielded specific, detailed information regarding publicly available documentation portals, comprehensive user manuals, or tiered support structures for either tool. Both mention general customer support and training, but without more specific details, a definitive comparison is not possible.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AngioWaveNet SENSICARDIAC
Name AngioWaveNet SENSICARDIAC
Company Angiowave Imaging DIACOUSTIC MEDICAL (PTY)
Primary Function AI software that enhances fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories. AI-powered, cloud-based heart murmur detection service that classifies murmurs as pathological or physiological.
Key Technology AI-powered Spatiotemporal Enhancement Processing (STEPu2122) AI-powered heart murmur detection
Integration Integrates with existing Cath lab workflows; Compatible with any fluoroscopic angiography system (vendor-agnostic); Functions as a DICOM endpoint. Integration with electronic stethoscopes (e.g., 3M Littmannu00ae 3200)
Target Output Improved vessel visualization in fluoroscopic angiograms; Enhanced visibility of blood vessels, vascular structures, and anatomical features. Classification of murmurs (Class I: dangerous pathological, Class III: innocent physiological); Detailed cardiac reports (downloadable PDFs, visualization, S1/S2 indicators).

Videos

Demos, reviews, and walkthroughs featuring AngioWaveNet and SENSICARDIAC.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AngioWaveNet integrates as a post-processing step within existing cath lab workflows, providing enhanced vessel visualization for interventional procedures to potentially improve diagnostic clarity. SENSICARDIAC, conversely, integrates with electronic stethoscopes during patient examinations, offering real-time AI classification of heart murmurs to aid in immediate diagnostic decisions and referral management.
AngioWaveNet functions as a DICOM endpoint, allowing enhanced angiographic images to be integrated into existing PACS and potentially the EHR for review. SENSICARDIAC generates detailed cardiac reports in PDF format, which can be downloaded and then manually or via an integration layer, incorporated into the patient's electronic health record.
For AngioWaveNet, physicians would need to understand the quantitative improvement in diagnostic accuracy or reduction in procedural complications resulting from enhanced vessel visualization. For SENSICARDIAC, information on the reported sensitivity and specificity for classifying pathological versus physiological murmurs, based on its validated database analysis, would be crucial for clinical confidence.
AngioWaveNet, as a post-processing tool, likely has a minimal learning curve for interpreting the enhanced images within existing review workflows. SENSICARDIAC, with its guided auscultation process, may require a brief training period for optimal stethoscope use and interpretation of real-time AI classifications and detailed reports.
For AngioWaveNet, understanding data encryption at rest and in transit for images, and robust access controls for the DICOM endpoint, is important. For SENSICARDIAC, given its cloud-based nature and real-time physiological data streaming, details on end-to-end encryption, data anonymization, and strong access management protocols would be critical.
AngioWaveNet should provide logs detailing when images were processed, by whom, and the parameters of enhancement applied. SENSICARDIAC should offer an audit trail for each auscultation event, including the user, timestamp, AI classification, and any generated reports to ensure clear accountability.
AngioWaveNet's vendor-agnostic compatibility and DICOM endpoint functionality suggest adaptability across various cath lab setups, requiring assessment of network infrastructure for image transfer. SENSICARDIAC's cloud-based nature and integration with electronic stethoscopes make it scalable across multiple sites, primarily requiring internet connectivity and distribution of compatible stethoscopes.
AI Tool Finder
AI-powered search. Results may not be comprehensive.